Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Association between anticoagulant therapy, exacerbations and mortality in a Danish cohort of patients with Chronic Obstructive Pulmonary Disease

Research output: Contribution to journalJournal articlepeer-review

View graph of relations

OBJECTIVES: Pulmonary Embolism has been frequently reported in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AE-COPD). The study aimed to determine whether COPD patients who receive anticoagulant (AC) therapy have a reduced risk of hospitalization due to AE-COPD and death.

METHODS: This nationwide population-based study was based on data from the Danish Register of COPD (DrCOPD), which contains complete data on COPD outpatients between 1st January 2010 and 31st December 2018. National registers were used to obtain information regarding comorbidities and vital status. Propensity-score matching and Cox proportional hazards models were used to assess AE-COPD and death after one year.

RESULTS: The study cohort consisted of 58,067 patients with COPD. Of these, 5194 patients were on AC therapy. The population was matched 1:1 based on clinical confounders and AC therapy, resulting in two groups of 5180 patients. We found no association between AC therapy and AE-COPD or all-cause mortality in the propensity-score matched population (HR 1.03, 95% CI 0.96-1.10, p = 0.37). These findings were confirmed in a competing risk analysis. In the sensitivity analysis, we performed an adjusted analysis of the complete cohort and found a slightly increased risk of AE-COPD or death in patients treated with AC therapy. This study found a low incidence of pulmonary embolisms and deep venous thrombosis in both groups.

CONCLUSIONS: AC therapy was not associated with the risk of hospitalization due to AE-COPD or all-cause mortality.

Original languageEnglish
Article number368504221104331
JournalScience progress
Issue number2
Pages (from-to)1-15
Number of pages15
Publication statusPublished - 9 Jun 2022

    Research areas

  • Anticoagulants/therapeutic use, Cohort Studies, Denmark/epidemiology, Hospitalization, Humans, Pulmonary Disease, Chronic Obstructive/drug therapy, Pulmonary Embolism/drug therapy, Chronic obstructive pulmonary disease, pulmonary embolism, COPD, anticoagulant therapy, venous tromboembolism

ID: 78438381